Literature DB >> 639835

Liver size and indices of drug metabolism in alcoholics.

H I Pirttiaho, E A Sotaniemi, J Ahlqvist, U Pitkänen, R O Pelkonen.   

Abstract

The role of liver size in drug metabolism was investigated in 34 chronic alcoholics and 28 controls by comparing antipyrine half-life with biopsy content and total amount of hepatic cytochrome P-450 (P-450) and liver weight. Liver size was significantly greater in alcoholics than in controls. Total P-450 was increased and antipyrine metabolism was enhanced in alcoholics with normal histology of the liver. In subjects with alcoholic hepatitis or cirrhosis, the antipyrine half-life was prolonged and P-450 was decreased. Alcoholics with fatty liver had a reduced P-450 content, but the total amount of P-450 and the antipyrine half-life were normal. The results demonstrate in alcoholics that an enlarged liver of normal histological appearance is associated with enhanced drug metabolism. In subjects with fatty liver the drug metabolizing capacity per unit weight of liver is often impaired, but the increase in liver size leads to undisturbed total oxidizing capacity and normal in vivo metabolism. In alcoholic hepatitis drug metabolism is impaired in spite of hepatomegaly. In cirrhosis the enlargement of the liver appears to compensate for the decreased P-450 content resulting in only slightly decreased total P-450, and the severly impaired in vivo drug metabolism may be due to derangement of blood flow.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 639835     DOI: 10.1007/BF00606684

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  33 in total

1.  The use of antipyrine in the measurement of total body water in man.

Authors:  R SOBERMAN; B B BRODIE
Journal:  J Biol Chem       Date:  1949-05       Impact factor: 5.157

Review 2.  Differences in hepatic and metabolic changes after acute and chronic alcohol consumption.

Authors:  C S Lieber; R Teschke; Y Hasumura; L M Decarli
Journal:  Fed Proc       Date:  1975-10

3.  Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technic.

Authors:  J N Cohn; I M Khatri; R J Groszmann; B Kotelanski
Journal:  Am J Med       Date:  1972-12       Impact factor: 4.965

4.  Drug metabolism and androgen control therapy in prostatic cancer.

Authors:  E A Sotaniemi; M J Kontturi; T K Larmi
Journal:  Clin Pharmacol Ther       Date:  1973 May-Jun       Impact factor: 6.875

5.  Genetic and environmental factors affecting ethanol metabolism in man.

Authors:  E S Vesell; J G Page; G T Passananti
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

6.  [Specific liver function: liver volume as reference parameter of the function].

Authors:  A Halpern; J Bircher; J Tauber; R Blankart; H Rösler; R Preisig
Journal:  Schweiz Med Wochenschr       Date:  1971-05-22

7.  Alcoholic hepatomegaly: accumulation of protein in the liver.

Authors:  E Baraona; M A Leo; S A Borowsky; C S Lieber
Journal:  Science       Date:  1975-11-21       Impact factor: 47.728

8.  Determinants of serum antipyrine half-lives in patients with liver disease.

Authors:  R A Branch; C M Herbert; A E Read
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

9.  Ethanol increases hepatic smooth endoplasmic reticulum and drug-metabolizing enzymes.

Authors:  E Rubin; F Hutterer; C S Lieber
Journal:  Science       Date:  1968-03-29       Impact factor: 47.728

10.  Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding.

Authors:  C S Lieber; L M DeCarli
Journal:  Science       Date:  1968-11-22       Impact factor: 47.728

View more
  11 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  The 14C-aminophenazone breath test in pesticide workers.

Authors:  B Dietze; K O Haustein; G Hüller; C Brückner
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

3.  Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

Authors:  J Reichen; B Egger; N Ohara; T B Zeltner; T Zysset; A Zimmermann
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Influence of ethanol on the interaction between polychlorinated biphenyls and drug metabolism.

Authors:  V Krampl; M Kontskova; J Kramplova
Journal:  Bull Environ Contam Toxicol       Date:  1980-11       Impact factor: 2.151

5.  Liver size and indices of drug metabolism in epileptics.

Authors:  H I Pirttiaho; E A Sotaniemi; J T Ahokas; U Pitkänen
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

6.  Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen; M Anttila; H Sundqvist
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

7.  A morphometric analysis of the hypertrophy of experimental liver cirrhosis.

Authors:  J W Ryoo; R J Buschmann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

Review 8.  Drug interactions with alcohol.

Authors:  M Linnoila; M J Mattila; B S Kitchell
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

9.  Cyclobarbital as a test substance for oxidative drug metabolism in man. Findings in neuropsychiatric patients.

Authors:  U Breyer-Pfaff; H Jerg; F Petruch
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

10.  Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers.

Authors:  M Hildebrand; A Hellstern; M Hümpel; D Hellenbrecht; R Saller
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jan-Mar       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.